Does PDE4 inhibition improve alveolarisation in hyperoxia-exposed immature rodents?
Méhats
C
C
Bourbon
J
J
Jarreau
P-H
PH
D000818:Animals; D000831:Animals, Newborn; D015153:Blotting, Western; D002264:Carboxylic Acids / Q000494:pharmacology; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4 / Q000378:metabolism*; D003509:Cyclohexanecarboxylic Acids; D018496:Hyperoxia / Q000201:enzymology*; D008170:Lung Compliance / Q000187:drug effects; D051379:Mice; D008810:Mice, Inbred C57BL; D009570:Nitriles / Q000494:pharmacology*; D010726:Phosphodiesterase Inhibitors / Q000494:pharmacology*; D011650:Pulmonary Alveoli / Q000201:enzymology*; D020133:Reverse Transcriptase Polymerase Chain Reaction
D002264:Carboxylic Acids; D003509:Cyclohexanecarboxylic Acids; D009570:Nitriles; D010726:Phosphodiesterase Inhibitors; C433247:Cilomilast; D054703:Cyclic Nucleotide Phosphodiesterases, Type 4